Published in Expert Rev Vaccines on June 01, 2010
Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio (2014) 3.49
Emerging biomedical applications of synthetic biology. Nat Rev Genet (2011) 2.05
Serological studies confirm the novel astrovirus HMOAstV-C as a highly prevalent human infectious agent. PLoS One (2011) 1.46
Antibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA). PLoS Negl Trop Dis (2012) 1.15
Synthetic biology for translational research. Am J Transl Res (2010) 1.10
Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity. Mol Ther (2012) 1.06
Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems. Expert Rev Proteomics (2011) 1.04
LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV, HIV and EBV. Mol Biosyst (2011) 1.04
Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases. Transl Res (2014) 0.98
Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome. J Dent Res (2011) 0.98
Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med (2010) 0.89
Microfluidic LIPS for serum antibody detection: demonstration of a rapid test for HSV-2 infection. Biomed Microdevices (2011) 0.85
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight (2016) 0.84
Rhesus and human cytomegalovirus glycoprotein L are required for infection and cell-to-cell spread of virus but cannot complement each other. J Virol (2010) 0.83
New technologies for studying the complexity of oral diseases. Oral Dis (2011) 0.82
Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis. Neuromuscul Disord (2010) 0.82
Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture. BMC Microbiol (2015) 0.79
New autoantibody detection technologies yield novel insights into autoimmune disease. Curr Opin Rheumatol (2014) 0.79
Altered antibody profiles against common infectious agents in chronic disease. PLoS One (2013) 0.78
Progress and challenges associated with the development of ricin toxin subunit vaccines. Expert Rev Vaccines (2016) 0.78
Investigating a mystery disease: tales from a viral detective. J Virol (2014) 0.77
The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2. Biologicals (2013) 0.77
Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort. Oncotarget (2016) 0.77
Antibody profiling of Borrelia burgdorferi infection in horses. Clin Vaccine Immunol (2011) 0.77
Antibody Engineering for Pursuing a Healthier Future. Front Microbiol (2017) 0.75
Luciferase Immunoprecipitation System Assay, a Rapid, Simple, Quantitative, and Highly Sensitive Antibody Detection for Parasitic Diseases. Iran J Parasitol (2017) 0.75
Ultrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune Complexes. Sci Rep (2017) 0.75
Methods to measure vaccine immunity. Expert Rev Vaccines (2010) 0.75
Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol (2003) 3.76
Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A (2005) 3.59
Self-assembling protein microarrays. Science (2004) 3.37
Suppression of non-specific binding in serological Luminex assays. J Immunol Methods (2005) 2.96
A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am J Clin Pathol (2002) 2.72
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol (2005) 2.72
A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis (2008) 2.65
Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). Biochem Biophys Res Commun (2006) 2.56
Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics (2008) 2.43
A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol (2005) 2.41
Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol (2005) 2.18
A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun (2008) 2.15
Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics (2007) 2.10
A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proc Natl Acad Sci U S A (2009) 2.10
Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b. Clin Diagn Lab Immunol (2002) 2.01
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94
Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp (2009) 1.93
A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis (2009) 1.89
Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun (2008) 1.87
Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics (2007) 1.85
Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol (2007) 1.75
From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics (2007) 1.68
Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection. J Clin Microbiol (2008) 1.65
Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Clin Vaccine Immunol (2009) 1.46
Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection. Clin Vaccine Immunol (2009) 1.45
Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology (2008) 1.45
Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc Natl Acad Sci U S A (2006) 1.31
Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays. Infect Immun (2009) 1.30
A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin. Infect Immun (2008) 1.28
Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. J Infect Dis (2009) 1.26
A multi-epitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in radioimmunoprecipitation-confirmed and consensus-positive sera. J Infect Dis (1999) 1.25
Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies. Clin Vaccine Immunol (2006) 1.24
Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin Vaccine Immunol (2008) 1.22
Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection. J Clin Microbiol (2006) 1.21
Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis (2007) 1.20
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies. Virol J (2009) 1.17
Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. J Infect Dis (2009) 1.17
Genome scale identification of Treponema pallidum antigens. Infect Immun (2005) 1.14
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. J Infect Dis (2010) 1.12
Reactivity of antibodies from syphilis patients to a protein array representing the Treponema pallidum proteome. J Clin Microbiol (2006) 1.11
Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta. Diabetes Care (2010) 1.10
Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. J Immunol Methods (2009) 1.10
Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol (2000) 1.09
Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis. Mol Cell Proteomics (2008) 1.05
Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays. Vaccine (2009) 1.05
Elimination of false-positive results in a luminex assay for pneumococcal antibodies. Clin Vaccine Immunol (2009) 1.02
Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients. J Infect Dis (2010) 1.01
Rapid serological detection of autoantibodies associated with Sjögren's syndrome. J Transl Med (2009) 0.93
A highly sensitive enzyme-linked immunosorbent assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340. J Virol Methods (1984) 0.89
Sensitive and specific serodiagnosis of onchocerciasis with recombinant hybrid proteins. Am J Trop Med Hyg (2002) 0.88
The role of a recombinant hybrid protein based ELISA for the serodiagnosis of Onchocerca volvulus. J Clin Pathol (2007) 0.86
Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity. Mol Biochem Parasitol (2007) 0.81
A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis (2008) 2.65
Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). Biochem Biophys Res Commun (2006) 2.56
Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest (2004) 2.28
Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain (2004) 2.17
Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp (2009) 1.93
A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis (2009) 1.89
Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol (2012) 1.80
Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection. J Clin Microbiol (2008) 1.65
Reproducibility of pain measurement and pain perception. Pain (2002) 1.64
High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem Biophys Res Commun (2007) 1.60
Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood (2010) 1.56
A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2. Diabetes Care (2008) 1.50
Direct interstitial infusion of NK1-targeted neurotoxin into the spinal cord: a computational model. Am J Physiol Regul Integr Comp Physiol (2003) 1.50
Serological studies confirm the novel astrovirus HMOAstV-C as a highly prevalent human infectious agent. PLoS One (2011) 1.46
Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Clin Vaccine Immunol (2009) 1.46
Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection. Clin Vaccine Immunol (2009) 1.45
Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology (2008) 1.45
Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology (2005) 1.41
Cyclin-dependent kinase 5 activity regulates pain signaling. Proc Natl Acad Sci U S A (2006) 1.34
Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc Natl Acad Sci U S A (2006) 1.31
Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome. Autoimmunity (2009) 1.31
Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem (2008) 1.30
Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol (2010) 1.25
Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci U S A (2005) 1.21
Comparison of experimental and acute clinical pain responses in humans as pain phenotypes. J Pain (2004) 1.20
Peripherally induced resiniferatoxin analgesia. Pain (2003) 1.17
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies. Virol J (2009) 1.17
Vanilloid receptor 1 regulates multiple calcium compartments and contributes to Ca2+-induced Ca2+ release in sensory neurons. J Biol Chem (2004) 1.15
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. J Infect Dis (2010) 1.12
Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates. Mol Pain (2010) 1.12
Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta. Diabetes Care (2010) 1.10
Synthetic biology for translational research. Am J Transl Res (2010) 1.10
Peripheral inflammation increases Scya2 expression in sensory ganglia and cytokine and endothelial related gene expression in inflamed tissue. J Neurochem (2007) 1.07
Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain (2010) 1.06
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain (2013) 1.06
Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways. J Biol Chem (2002) 1.05
Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems. Expert Rev Proteomics (2011) 1.04
Two major autoantibody clusters in systemic lupus erythematosus. PLoS One (2012) 1.04
LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV, HIV and EBV. Mol Biosyst (2011) 1.04
Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients. J Infect Dis (2010) 1.01
Spinal cord NR1 serine phosphorylation and NR2B subunit suppression following peripheral inflammation. Mol Pain (2005) 0.99
Peripheral targeting of the trigeminal ganglion via the infraorbital foramen as a therapeutic strategy. Brain Res Brain Res Protoc (2005) 0.98
Rapid serological detection of autoantibodies associated with Sjögren's syndrome. J Transl Med (2009) 0.93
Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells. Neurotoxicology (2003) 0.93
Extraordinary antigenicity of the human Ro52 autoantigen. Am J Transl Res (2010) 0.93
Resveratrol inhibits Cdk5 activity through regulation of p35 expression. Mol Pain (2011) 0.92
Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain (2003) 0.91
Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons. J Biol Chem (2012) 0.91
Modulatory role of neuropeptide FF system in nociception and opiate analgesia. Neuropeptides (2007) 0.91
Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther (2011) 0.90
Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med (2010) 0.89
Extrapancreatic autoantibody profiles in type I diabetes. PLoS One (2012) 0.88
Localization of S100A8 and S100A9 expressing neutrophils to spinal cord during peripheral tissue inflammation. Pain (2007) 0.87
Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol Pain (2008) 0.87
Lack of serum antibodies against Borrelia burgdorferi in children with autism. Clin Vaccine Immunol (2013) 0.87
Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1). Bioorg Med Chem (2008) 0.87
Microfluidic LIPS for serum antibody detection: demonstration of a rapid test for HSV-2 infection. Biomed Microdevices (2011) 0.85
Intrathecal resiniferatoxin in a dog model: efficacy in bone cancer pain. Pain (2015) 0.84
TGF-β1 sensitizes TRPV1 through Cdk5 signaling in odontoblast-like cells. Mol Pain (2013) 0.83
High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance. J Neuroimmunol (2010) 0.83
Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis. Neuromuscul Disord (2010) 0.82
No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Am J Transl Res (2012) 0.80
RT-PCR analysis of pain genes: use of gel-based RT-PCR for studying induced and tissue-enriched gene expression. Methods Mol Biol (2010) 0.80
Cytokine gene expression after total hip arthroplasty: surgical site versus circulating neutrophil response. Anesth Analg (2009) 0.79
Complete pain relief: potential problems and diagnostic solutions. Nat Clin Pract Neurol (2007) 0.79
Altered antibody profiles against common infectious agents in chronic disease. PLoS One (2013) 0.78
Positive allosteric modulation of TRPV1 as a novel analgesic mechanism. Mol Pain (2012) 0.78
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells. Arthritis Rheumatol (2014) 0.77
The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma. AIDS Res Treat (2012) 0.77
Antibody profiling of Borrelia burgdorferi infection in horses. Clin Vaccine Immunol (2011) 0.77
Modulatory roles of the NPFF system in pain mechanisms at the spinal level. Peptides (2006) 0.77
Measurement of resiniferatoxin in serum samples by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.76
Emerging tactical strategies for fighting the war on cancer based on the genetic landscape. Am J Transl Res (2011) 0.76
A new splice of life for the μ-opioid receptor. J Clin Invest (2015) 0.75
Thermal A-δ Nociceptors, Identified by Transcriptomics, Express Higher Levels of Anesthesia-Sensitive Receptors Than Thermal C-Fibers and Are More Suppressible by Low-Dose Isoflurane. Anesth Analg (2017) 0.75
Measurement of resiniferatoxin in cerebrospinal fluid by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.75